Public Profile

Aarti Drugs

Aarti Drugs Limited, commonly referred to as Aarti Drugs, is a prominent player in the pharmaceutical industry, headquartered in Mumbai, India. Established in 1984, the company has made significant strides in the production of active pharmaceutical ingredients (APIs) and formulations, catering to both domestic and international markets. With a diverse portfolio that includes anti-infectives, analgesics, and cardiovascular medications, Aarti Drugs stands out for its commitment to quality and innovation. The company has achieved several milestones, including regulatory approvals from major global health authorities, which solidify its market position. Recognised for its robust manufacturing capabilities and a strong emphasis on research and development, Aarti Drugs continues to contribute to the healthcare sector, ensuring the availability of essential medicines worldwide.

DitchCarbon Score

How does Aarti Drugs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Aarti Drugs's score of 27 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

92%

Let us know if this data was useful to you

Aarti Drugs's reported carbon emissions

In 2024, Aarti Drugs reported total carbon emissions of approximately 54,834,000 kg CO2e for Scope 1 and about 80,250,000 kg CO2e for Scope 2, resulting in a combined total of around 135,084,000 kg CO2e. This marks a slight increase in Scope 2 emissions compared to 2023, where they recorded approximately 76,414,000 kg CO2e for Scope 2 and 54,834,000 kg CO2e for Scope 1, totalling about 135,084,000 kg CO2e. Aarti Drugs has set ambitious climate commitments, aiming to reduce both Scope 1 and Scope 2 emissions by 50% by 2030, using 2020 as the baseline year. This commitment reflects the company's proactive approach to mitigating its carbon footprint and aligns with industry standards for sustainability. The company has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. Overall, Aarti Drugs is taking significant steps towards enhancing its environmental performance and addressing climate change challenges.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
84,380,000
00,000,000
00,000,000
00,000,000
Scope 2
104,966,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aarti Drugs's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Aarti Drugs is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Aarti Drugs is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Shilpa Medicare

IN
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

SMS Pharmaceuticals Ltd

IN
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Morepen

IN
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Granules India

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Glenmark Life Sciences

IN
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Dishman Pharmaceuticals and Chemicals Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers